|
Issue |
Title |
|
Vol 2, Issue 2 (2022) |
Pharmacogenetic Testing of Cytochrome P450 System Enzymes in the Therapy of Bipolar Affective Disorder |
Abstract
PDF (Eng)
|
A. K. Khasanova, R. F. Nasyrova |
|
Vol 2, Issue 2 (2022) |
Clinical Case of a 36-year-old Patient with Paranoid Schizophrenia and Drug-Induced QT Prolongation |
Abstract
PDF (Eng)
|
N. M. Zhuravlev, A. P. Otmachov, A. E. Bartasinskaya |
|
Vol 2, Issue 1 (2022) |
Pharmacogenetic Testing of Cytochrome P450 Metabolizing Enzymes in 28-Year-Old Man with Treatment-Resistant Schizophrenia |
Abstract
PDF (Eng)
|
A. K. Abdyrakhmanova, R. F. Nasyrova |
|
Vol 2, Issue 1 (2022) |
Clinical Case of a 36-Year-Old Man with Treatment-Resistant Paranoid Schizophrenia: Personalized Therapy Selection |
Abstract
PDF (Eng)
|
L. P. Linova, A. A. Torgovtsev, O. V. Limankin, R. F. Nasyrova |
|
Vol 2, Issue 1 (2022) |
Pharmacogenetic Testing of Antipsychotic Transporter Proteins: A Case Report in a 32-Year-Old Woman with Treatment-Resistant Schizophrenia |
Abstract
PDF (Eng)
|
S M. Osipova, N. A. Shnayder |
|
11 - 15 of 15 Items |
<< < 1 2
|